Authors


Rakhshanda Akram, MD

Latest:

What's in the Pipeline?

A look at up-and-coming HIV drugs in development.



SHELLEY HANKINS, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Dava Stewart

Latest:

Using Deep Sequencing Technology to Detect HCV Resistant Variants

A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.



Contagion&reg Editorial Staff

Latest:

The ID Pipeline: Drug Development Debrief | Week of September 13, 2020

A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.


Jose A. Vazquez, MD

Latest:

Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.


Brandon May

Latest:

MSM Who Use Mobile Apps for Sex More Likely to Have STIs

Men who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.


Debra Goff, PharmD, FCCP

Latest:

The Significance of Antimicrobial Stewardship in Dentistry

Debra Goff, PharmD, discusses her advocacy around this topic and bringing the stewardship message to dentists about how antibiotic prescribing practices have changed and getting them to recalibrate their thinking and actions in their field.


Amanda Binkley, PharmD, AAHIVP

Latest:

Treatment as Prevention: A Comprehensive Approach to Hepatitis C Virus in Persons Who Inject Drugs

With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.


Daniela Dimarco, MD

Latest:

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.



Ilia Rochlin, PhD

Latest:

Tick, Tick, Tick: Vector-Borne Diseases Ramp Up

Infections transmitted by these bloodsucking species are on the rise worldwide.



Amesh A. Adalja, MD, FIDSA

Latest:

Will Pennsylvania Proposal Sanction Improper Treatment of Lyme Disease?

Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.


Lori Strazdas, MPH

Latest:

Manual Surface Disinfectants Must Continue to Evolve to Meet Changing Health Care Needs

Many health care facilities are looking to expand the use of broad-spectrum sporicidal disinfectants beyond patient isolation rooms to better address the role of the environment in pathogen transmission and acquisition.


Contagion Editorial Team

Latest:

Top 5 Infectious Disease News Stories Week of March 22-29

This week, the FDA approved two new drugs, gepotidacin for treating uUTIs in females aged 12 and older, and Tesamorelin F8 for managing excess abdominal fat in adults with HIV-associated lipodystrophy.


Dimple Patel, PharmD

Latest:

CREating New Strategies for the Treatment of Resistant Gram-Negative Infections

This was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.


Khalid Eljaaly, PharmD, BCPS, CAPP

Latest:

Changes in Therapy Guideline for Nosocomial Pneumonia

Contagion® Editorial Advisory Board member, Khalid Eljaaly, PharmD, BCPS, CAPP, discusses key updates in the Infectious Diseases Society of America and the American Thoracic Society recommendations.


Kerry Lengyel

Latest:

NIH Awards $4.8 Million to University to Fight Potentially Fatal Fungal Infection

The National Institutes of Health has awarded a 4-year, $4.8 million grant to the University of Arizona to speed up the development of delta-CPS1, a vaccine candidate to fight valley fever.


Lisa Dumkow, PharmD, BCPS, BCIDP

Latest:

Best Practices for Getting Young Clinicians into Research

This time of year means new trainees will begin their careers and are excited to take on research projects. However, they may have limited to no experience in this area. Here is an opportunity to give them structure and guidance when committing to longitudinal trainee research.


Alexandra Ward

Latest:

China Confirms Case of Bubonic Plague

Health officials in China have confirmed a case of bubonic plague in a herdsman from the Inner Mongolia district, triggering increased prevention measures throughout the region.


Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Latest:

Will Trump Administration’s Funding Pauses, Withdrawal from WHO Hamper Public Health?

This is the second in a series looking at the intersection of government and public health. In this segment, Contagion Editor-in-Chief Jason Gallagher, FCCP, FIDP, FIDSA, BCPS, discusses the WHO pullout, and the pauses on federal communication and research grants.


Gail Connor Roche

Latest:

Lower Respiratory Infections Linked with Influenza Lead to Substantial Global Health Loss

In 2017, lower respiratory tract infections linked with influenza were responsible for an estimated 145,000 deaths worldwide.


Courtney Moc, PharmD, MS

Latest:

Current and Potential Treatment Options for Stenotrophomonas maltophilia Infections

We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.


Amesh A. Adalja, MD

Latest:

COVID-19: A Primer

This virus has multiple facets and highlights a need for real-time learning.



Rhonda E. Colombo, MD, MHS

Latest:

Examining An Emergence of Multi-drug Resistance Among Candida Species

Despite having emerged as either the third or fourth leading cause of blood stream infections in the United States, the threat of multi-drug resistant Candida species remains an underappreciated concern.


Adriano de Bernardi Schneider, MSc

Latest:

What Can We Learn From Outbreaks of HIV and Zika?

Parallels between the recent Zika epidemic in Brazil and the HIV pandemic in the 1980s, stress the importance of improving responses to public health crises.


Jason M. Pogue, PharmD

Latest:

Emerging Resistance in Pseudomonas Treatment: Key Insights from the CACTUS Study

Exploring the challenges and strategies for combating MDR Pseudomonas aeruginosa infections, as discussed with Jason Pogue, PharmD, BCPS, BCIDP

© 2025 MJH Life Sciences

All rights reserved.